Better Buy: Veeva Systems Inc Vs. Athenahealth, Inc

Software is eating the world. Or, at least, that's what famed angel investor Marc Andreessen told The Wall Street Journal back in 2011. The past seven years have proven that thesis out, as software-as-a-service (SaaS) companies have come to dominate many industries.The low-overhead, easily deployed model of delivery -- combined with the reliability of sticky recurring revenue -- has meant that investments in such companies have proven very lucrative. The healthcare field is no exception to this rule, and today, two upstarts -- pharmaceutical cloud player Veeva Systems (NYSE: VEEV) and electronic health records and billing specialist athenahealth (NASDAQ: ATHN) -- go head to head.Continue reading

BING NEWS:
  • New Veeva Pulse Findings Show Connected Engagement Creates an Advantage as HCP Access Drops
    The latest Veeva Pulse findings on HCP access reveal that: Access drops but HCPs want to expand engagement channels: With 45% accessible to biopharmas compared to 60% in 2022, HCPs open to in-person ...
    05/23/2024 - 12:10 am | View Link
  • For the Second Year in a Row, Veeva MedTech Named Best Overall Medtech Software
    Annual MedTech Breakthrough Awards program recognizes leading companies in medical devices and diagnostics ...
    05/22/2024 - 12:14 am | View Link
  • Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH) and Sarepta Therapeutics (SRPT)
    Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Definitive Healthcare Corp (DH – Research ...
    05/21/2024 - 11:00 pm | View Link
  • Veeva Systems (VEEV) Stock Drops Despite Market Gains: Important Facts to Note
    Veeva Systems (VEEV) closed at $209.24 in the latest trading session, marking a -0.34% move from the prior day. This move lagged the S&P 500's daily gain of 0.25%. At the same time, the Dow added 0.17 ...
    05/21/2024 - 10:50 am | View Link
  • Barclays Reaffirms Their Buy Rating on Veeva Systems (VEEV)
    Barclays analyst Saket Kalia maintained a Buy rating on Veeva Systems (VEEV – Research Report) today and set a price target of $245.00.
    05/20/2024 - 8:46 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News